Cheng, Heather H.
Fred Hutch Cancer Center
7 papers on CoChatORCID 0000-0002-1365-0702
Most cited papers
- Verified
Integrative Clinical Genomics of Advanced Prostate Cancer
Robinson, D., Van Allen, E. M., Wu, Y.-M., Schultz, N., Lonigro, R. J., Mosquera, J.-M., Montgomery, B., Taplin, M.-E., Pritchard, C. C., Attard, G., et al. (2015) · Cell
Prostate Cancer Treatment and ResearchCancer Genomics and Diagnostics
Cited by 3,645
- Verified
MicroRNA profiling: approaches and considerations
Pritchard, C. C., Cheng, H. H., & Tewari, M. (2012) · Nature Reviews Genetics
MicroRNA in disease regulationGene expression and cancer classification
Cited by 1,765
- Verified
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
Pritchard, C. C., Mateo, J., Walsh, M. F., De Sarkar, N., Abida, W., Beltran, H., Garofalo, A., Gulati, R., Carreira, S., Eeles, R., et al. (2016) · New England Journal of Medicine
BRCA gene mutations in cancerGenetic factors in colorectal cancer
Cited by 1,680
- Verified
Plasma processing conditions substantially influence circulating microRNA biomarker levels
Cheng, H. H., Yi, H. S., Kim, Y., Kroh, E. M., Chien, J. W., Eaton, K. D., Goodman, M. T., Tait, J. F., Tewari, M., & Pritchard, C. C. (2013) · PLoS ONE
MicroRNA in disease regulationExtracellular vesicles in disease
Cited by 317
- Verified
Prostate Cancer, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology
Spratt, D. E., Srinivas, S., Adra, N., Ahmed, B., An, Y., Bitting, R., Chapin, B., Cheng, H. H., Cho, S. Y., D’Amico, A. V., et al. (2025) · Journal of the National Comprehensive Cancer Network
Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and Treatment
Cited by 146
- Verified
Mismatch repair deficiency in metastatic prostate cancer: Response to PD-1 blockade and standard therapies
Graham, L. S., Montgomery, B., Cheng, H. H., Yu, E. Y., Nelson, P. S., Pritchard, C., Erickson, S., Alva, A., & Schweizer, M. T. (2020) · PLOS ONE
Prostate Cancer Treatment and ResearchCancer Immunotherapy and Biomarkers
Cited by 114
- Verified
Germline and somatic genomic testing for metastatic prostate cancer: ASCO guideline
Yu, E. Y., Rumble, R. B., Agarwal, N., Cheng, H. H., Eggener, S. E., Bitting, R. L., Beltran, H., Giri, V. N., Spratt, D., Mahal, B., et al. (2025) · Journal of Clinical Oncology
Prostate Cancer Treatment and ResearchCancer Genomics and Diagnostics
Cited by 64
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free